| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 06/23/2005 | WO2004046094A9 Histone deacetylase inhibitors |
| 06/23/2005 | WO2004041258A8 Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses |
| 06/23/2005 | WO2003056896A3 Use of cytokines secreted by dendritic cells |
| 06/23/2005 | US20050137384 Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation |
| 06/23/2005 | US20050137249 Cyclization at the 5,6-position of the benzo[e]naphtho[3,2-h]azulene, oxepane or thiepane with a mercaptoacetic acid ester followed by etherification, amination or sulfiding at the 2-position; antiarthritic and antiinflammatory agents, analgesics; biosynthesis inhibitors of interleukin-1; nontoxic |
| 06/23/2005 | US20050137214 Inhibitors of cyclin-dependent kinases 4 (cdk4); treating proliferative disorders such as cancer; salt of 6-Acetyl-8-cyclopentyl-5-methyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-8H-pyrido[2,3-d]pyrimidin-7-one for example |
| 06/23/2005 | US20050137180 Porphrins or azaporprins for photosensitizing therapy or photodetection with azaporprins for cardiovascular disorders and coordination with metals |
| 06/23/2005 | US20050137167 Inhibiting FGF growth factor with heparins; antitumor agents; angiogenesis inhibitor; antidiabetic agent treating diabetic retinopathy; antiinflammatory agent; treating retrolenticular fibroplasia, psoriasis, restenosis after angioplasty and after coronary by-pass; chemical intermediates; drug delivery |
| 06/23/2005 | US20050137112 determining lymphocyte epitopes in proteins comprising obtaining from blood, a solution of dendritic cells and CD4 antigens, then promoting cell differentiation, by exposing to cytokines, then mixing with peptides of interest and measuring the proliferation of lymphocytes |
| 06/23/2005 | US20050136133 Administering an anti-allergy composition of a wood-vinegar distilled solution, colorless and transparent |
| 06/23/2005 | US20050136074 Administering antigens capable of causing specific immune reaction(s) directed against an infectious agent and/or cells infected with the infectious agent, and decreasing a different specific immune reaction direct towards the infectious agent, infected cells and/or uninfected cells; immunotherapy |
| 06/23/2005 | US20050136073 Use of microparticles combined with submicron oil-in-water emulsions |
| 06/23/2005 | US20050136069 Immunogenic portion of Mycobacterium tuberculosis proteins and monophosphoryl lipid A as adjuvant; vaccines |
| 06/23/2005 | US20050136067 Multimeric hybrid gene having a gene sequence coding for an antigenic region of a protein from a first pathogen linked to a gene sequence coding for an antigenic region of a protein from a second pathogen, especially coding for a parainfluenza virus and a respiratory syncytial virus; vaccines |
| 06/23/2005 | US20050136054 Humanised antibodies |
| 06/23/2005 | US20050136041 Transgenic cell comprising nucleotide sequences coding erythropoietin and/or glucagon-like peptides for use in treatment and prevention of blood and metabolic disorders; somatic and germ cell gene therapy; tissue engineering |
| 06/23/2005 | DE10356248A1 Pharmazeutische Zusammensetzung zur Behandlung von Rhinitiden A pharmaceutical composition for the treatment of rhinitis |
| 06/23/2005 | CA2548929A1 Cell death inducing agent |
| 06/23/2005 | CA2548443A1 Use of chp as an inhibitor of glutathione s-transferases and collagen iv |
| 06/23/2005 | CA2546920A1 Methods for suppressing an immune response or treating a proliferative disorder |
| 06/23/2005 | CA2490218A1 Extracorporeal photopheresis in combination with anti-tnf treatment |
| 06/22/2005 | EP1544194A1 4-(substituted aryl)-5-hydroxyisoquinolinone derivative |
| 06/22/2005 | EP1543833A1 Phosphorylated dextran |
| 06/22/2005 | EP1543034A2 Treatment and prophylaxis with 4-1bb-binding agents |
| 06/22/2005 | EP1543024A2 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use |
| 06/22/2005 | EP1543009A1 Pyrrolotriazine kinase inhibitors |
| 06/22/2005 | EP1542980A1 5-aryltetrazole compounds, compositions thereof, and uses therefor |
| 06/22/2005 | EP1542978A1 Novel bio-active molecules |
| 06/22/2005 | EP1542977A1 2,5-dioxoimidazolidin-4-yl acetamides and analogues as inhibitors of metalloproteinase mmp12. |
| 06/22/2005 | EP1542972A2 Cyclooxygenase- 2 selective inhibitors, compositions and methods of use |
| 06/22/2005 | EP1542948A2 Novel biphenyl and biphenyl-like cannabinoids |
| 06/22/2005 | EP1542724A2 Antibodies directed to monocyte chemo-attractant protein-1 (mcp-1) and uses thereof |
| 06/22/2005 | EP1542715A1 Modulation of immune function |
| 06/22/2005 | EP1542692A1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain |
| 06/22/2005 | EP1469856A4 8-heteroaryl xanthine adenosine a sb 2b /sb receptor antagonists |
| 06/22/2005 | EP1372656B1 Pyrazolo[4,3-d]pyrimidinone compounds as cgmp pde inhibitors |
| 06/22/2005 | EP1345933B1 Process for making substituted 8-arylquinolinium benzenesulfonate |
| 06/22/2005 | EP1272200B1 Divided dose therapies with vascular damaging activity |
| 06/22/2005 | EP1267915B1 Activated protein c for treating pancreatitis |
| 06/22/2005 | EP1173201B1 Method for the treatment of fibrosis using an antagonist of the integrin alpha-4 subunit |
| 06/22/2005 | EP1171136B1 Immunomodulating compositions comprising urea derivatives for use in the treatment of inflammatory diseases |
| 06/22/2005 | EP1154774B1 Quinazoline derivatives as angiogenesis inhibitors |
| 06/22/2005 | EP1131039B1 Use of a substance binding with the peripheral benzodiazepin receptor for treating skin stress |
| 06/22/2005 | EP1073465B1 T cell inhibitory receptor compositions and uses thereof |
| 06/22/2005 | EP0927254B1 Antagonists of interleukin-15 |
| 06/22/2005 | CN1630730A Methods for detecting and treating the early onset of aging-related conditions |
| 06/22/2005 | CN1630724A Compositions and methods for inhibiting expression of a target gene |
| 06/22/2005 | CN1630716A Hematopoietic cells from human embryonic stem cells |
| 06/22/2005 | CN1630714A Circadian control of stem/progenitor cell self-renewal and differentiation and of clock controlled gene expression |
| 06/22/2005 | CN1630664A Caspase-8 binding protein, its preparation and use |
| 06/22/2005 | CN1630657A Deazapurines and uses thereof |
| 06/22/2005 | CN1630656A Dihydropyrazolopyridine compounds and pharmaceutical use thereof |
| 06/22/2005 | CN1630635A Amino alcohol derivatives or phosphonic acid derivatives and pharmaceutical compositions containing these |
| 06/22/2005 | CN1630633A N-biphenylmethyl aminocycloalkanecarboxamide derivatives with a substiituent on the methyl useful as bradykinin antagonists |
| 06/22/2005 | CN1630535A Inhibition of STAT-1 |
| 06/22/2005 | CN1630531A Composition comprising immunogenic microparticles |
| 06/22/2005 | CN1630526A Systems and methods for treating patients with processed lipoaspirate cells |
| 06/22/2005 | CN1630516A Combinations of antibodies selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and other therapeutic agents |
| 06/22/2005 | CN1630515A Compounds active at the glucocorticoid receptor II |
| 06/22/2005 | CN1630494A Ophthalmic drug delivery device |
| 06/22/2005 | CN1629285A Natural killer cell for transgenic expression cell chemotactic factors |
| 06/22/2005 | CN1629182A Oslasodine hydrochloride preparing process |
| 06/22/2005 | CN1628799A Clove leaf extract containing soft capsule and its preparation process |
| 06/22/2005 | CN1628776A Medicine for treating chronic hives |
| 06/22/2005 | CN1628757A Externally applied healthy medicinal formulation |
| 06/22/2005 | CN1628739A Improved method for preparing 'Zhenqi Fuzheng' medicine |
| 06/22/2005 | CN1628722A Compound dired Chinese forest frog oil capsule and its preparation |
| 06/22/2005 | CN1628693A Glossy ganoderma preparation containing main active substance of glossy ganoderma herb and preparing method thereof |
| 06/22/2005 | CN1628686A Radix salviae miltiorrhizae oligosaccharide and its application for resisting acquired immunodeficiency syndrome, adjusting immunity and increasing leukocyte |
| 06/22/2005 | CN1207306C Peptide compound for preventing and treating HIV infection and immunity diseases |
| 06/22/2005 | CN1207298C Triazolopurine derivatives, drug compositions containing the same and adenosine A3 receptor affinitive agents |
| 06/22/2005 | CN1207294C Acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as TACE inhibitors |
| 06/22/2005 | CN1207055C Preparation method of cordyceps biological activity multivitamin intensifying agent |
| 06/22/2005 | CN1207030C Natural bioreaction regulator with the functions of resisting cancer, resisting free radical damage and regulating immunity |
| 06/22/2005 | CN1206991C Preparation containing Cetirizine Hydrochloride and hydrochloric pseudoephedrine and its prepn. method |
| 06/21/2005 | US6909007 Steroidal pharmaceutical compounds |
| 06/21/2005 | US6908999 Process for the preparation of {2-[4-α-phenyl-p-chlorobenzyl)piperazin-1-yl]ethoxy} acetic acid and novel intermediates therefor |
| 06/21/2005 | US6908940 Imidazole compounds and their use as adenosine deaminase inhibitors |
| 06/21/2005 | US6908930 4-substituted 7-AZA-indolin-2-ones and their use as protein kinase inhibitors |
| 06/21/2005 | US6908920 Pyrimidine derivatives |
| 06/21/2005 | CA2309474C New 4-arylpiperidine derivatives for the treatment of pruritus |
| 06/21/2005 | CA2309473C New 4-arylpiperidine derivatives for the treatment of pruritus |
| 06/21/2005 | CA2250372C 6-phenylpyridyl-2-amine derivatives |
| 06/21/2005 | CA2108068C Carbamates of rapamycin |
| 06/21/2005 | CA2066304C Pharmaceutical composition for the treatment of autoimmune diseases |
| 06/16/2005 | WO2005054252A1 Crystal of hydrochloride of sulfoxide derivative |
| 06/16/2005 | WO2005054213A1 Isoxazole derivative having agonistic activity against peroxisome proliferator-activated receptor |
| 06/16/2005 | WO2005054199A1 Tubulin inhibitors |
| 06/16/2005 | WO2005053711A1 Gamma-interferon inducer |
| 06/16/2005 | WO2005053679A1 Novel use of silymarin and the composition comprising the same |
| 06/16/2005 | WO2005035786A3 Methods for the risk estimation of bronchiectasis using ifngamma and cxcr1 gene polymorphisms |
| 06/16/2005 | WO2005032589A8 Prevention and treatment for gvhd |
| 06/16/2005 | WO2005023305A3 Modulating cell activity by using an agent that reduces the level of cholesterol within a cell |
| 06/16/2005 | WO2005014653A3 Humanized chicken antibodies |
| 06/16/2005 | WO2005000235A3 NUCLEIC ACID SEQUENCES ENCODING AND COMPOSITIONS COMPRISING IgE SIGNAL PEPTIDE AND/OR IL-15 AND METHODS FOR USING THE SAME |
| 06/16/2005 | WO2004058753A8 Thiadiazoles or oxadiazoles and their use as inhibitors of jak protein kinase |
| 06/16/2005 | WO2004048565A9 Apoptosis-associated protein and use thereof |
| 06/16/2005 | US20050132428 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use |
| 06/16/2005 | US20050131236 Central nervous ystem disorders; neurodegenerative disorders; muscle contraction; endocrine diseases |
| 06/16/2005 | US20050131035 Medicaments |